Action PERRIGO
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues PERRIGO TEL AVIV STOCK EXCHANGE

Actions

Cours en clôture TEL AVIV STOCK EXCHANGE
Autres places de cotation
- ILa - Graphique intraday de PERRIGO
13/06 PERRIGO COMPANY PLC : Piper Sandler à l'achat ZM
11/06 Transcript : Perrigo Company plc Presents at Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference, Jun-11-2024 01:30 PM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Perrigo Company plc Appoints Todd Penegor as Member of Board and to Serve on Audit Committee, Effective June 21, 2024
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
Perrigo Company plc Announces Executive Changes
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
Perrigo's Q1 Adjusted Earnings, Net Sales Drop
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23
Perrigo: Q1 Earnings Snapshot
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024
Perrigo Company plc Reaffirms Earnings Guidance Year 2024 and Provides Sales Guidance for the Second Half of 2024
Perrigo Announces Executive Transition for Its Consumer Self-Care International Business
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31
Perrigo Announces Quarterly Dividend
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024
Sector Update: Health Care Stocks Decline Late Afternoon
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Esteve Healthcare S.L. signed a binding offer to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc for approximately ?280 million.
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
Opill and WNBA Team Up for Groundbreaking Partnership
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PRGO
  4. Action
  5. Actualités PERRIGO
  6. Autres langues